LifeStance Health Group, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
LifeStance Health Group, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2020 to Q3 2024.
  • LifeStance Health Group, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$5.43M, a 50.3% decline year-over-year.
  • LifeStance Health Group, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$22.1M, a 15.7% decline year-over-year.
  • LifeStance Health Group, Inc. annual Nonoperating Income (Expense) for 2023 was -$17.4M, a 22.6% increase from 2022.
  • LifeStance Health Group, Inc. annual Nonoperating Income (Expense) for 2022 was -$22.6M, a 51.8% increase from 2021.
  • LifeStance Health Group, Inc. annual Nonoperating Income (Expense) for 2021 was -$46.8M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$22.1M -$5.43M -$1.82M -50.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$20.3M -$6.67M -$3.07M -85% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$17.2M -$3.96M +$224K +5.35% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$17.4M -$6.05M +$1.66M +21.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$19.1M -$3.61M -$244K -7.25% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$18.9M -$3.61M +$3.73M +50.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$22.6M -$4.19M -$33K -0.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$22.6M -$7.7M -$2.83M -57.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$19.7M -$3.37M +$1.17M +25.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$20.9M -$7.33M +$19.4M +72.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$40.3M -$4.15M +$6.41M +60.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$46.8M -$4.88M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$4.54M +$2.52M +35.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$26.8M -$21M -360% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$10.6M +$23.1M +68.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 -$7.06M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$5.82M Apr 13, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$33.7M Apr 1, 2020 May 14, 2020 10-Q 2021-08-12
Q1 2020 -$36M Jan 1, 2020 May 14, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.